ImmunoGen Inc.

NASDAQ: IMGN · Real-Time Price · USD
31.23
0.00 (0.00%)
At close: Feb 09, 2024, 8:58 PM

ImmunoGen Statistics

Share Statistics

ImmunoGen has 279.35M shares outstanding. The number of shares has increased by 0% in one year.

279.35M
0%
0%
n/a
n/a
132
n/a

Short Selling Information

The latest short interest is 20.61M, so 7.38% of the outstanding shares have been sold short.

20.61M
7.38%
7.4%
5

Valuation Ratios

The PE ratio is -5.64 and the forward PE ratio is null. ImmunoGen's PEG ratio is 0.

-5.64
n/a
11.55
n/a
8.06
-5.44
0
Financial Ratio History

Enterprise Valuation

ImmunoGen has an Enterprise Value (EV) of 996.61M.

9.16
-4.58
-4.34
-4.31

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.1.

2.26
2.5
0.1
-0.07
-0.07
-53.04

Financial Efficiency

Return on Equity is -143.06% and Return on Invested Capital is -129.83%.

-143.06%
-63.89%
-129.83%
$392,714.8
$-804,797.83
277
0.31
-0.01

Taxes

1.22M
-0.55%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 1.17, so ImmunoGen's price volatility has been higher than the market average.

1.17
n/a
29.69
19.27
82.52
8,287,745

Income Statement

In the last 12 months, ImmunoGen had revenue of 108.78M and earned -222.93M in profits. Earnings per share was -0.88.

108.78M
108.61M
-220.89M
-222.93M
-217.55M
-217.55M
-0.88
Full Income Statement

Balance Sheet

The company has 275.14M in cash and 15.24M in debt, giving a net cash position of 259.89M.

275.14M
15.24M
259.89M
-1.69B
822.1M
601.57M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -229.8M and capital expenditures -1.36M, giving a free cash flow of -231.17M.

-229.8M
-1.36M
-231.17M
-0.91
Full Cash Flow Statement

Margins

Gross margin is 99.84%, with operating and profit margins of -203.06% and -204.93%.

99.84%
-203.06%
-203.81%
-204.93%
-199.98%
-203.06%
-212.5%

Dividends & Yields

IMGN does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
-17.74%
-18.4%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for IMGN.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

18.12
3